EC Number | Application | Comment | Organism |
---|---|---|---|
2.6.1.43 | medicine | immunological difference between the enzyme from mammalian source and this enzyme presents a potential target for chemotherapy, development of treatment for Leishmaniasis, a major parasitic disease in humans and opportunistic infections in patients with AIDS, an inhibitor specific for the leishmanial enzyme may be used as a therapeutic agent | Leishmania donovani |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.6.1.43 | hemin | - |
Leishmania donovani | |
2.6.1.43 | methylglyoxal | - |
Leishmania donovani |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.6.1.43 | 1.44 | - |
4,5-Dioxopentanoate | pH 7.0, 65°C | Leishmania donovani |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.6.1.43 | L-alanine + 4,5-dioxopentanoate | Leishmania donovani | first committed step in heme synthesis | 5-aminolevulinate + pyruvate | - |
ir |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.6.1.43 | Leishmania donovani | - |
AG83, WHO nomenclature MHOM/IN/83/AG83, promastigote form | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.6.1.43 | beta-alanine + 4,5-dioxopentanoate | 65.6% of the activity with L-alanine | Leishmania donovani | 5-aminolevulinate + malonic semialdehyde | - |
ir | |
2.6.1.43 | glycine + 4,5-dioxopentanoate | 81.2% of the activity with L-alanine | Leishmania donovani | 5-aminolevulinate + glyoxylate | - |
ir | |
2.6.1.43 | L-alanine + 4,5-dioxopentanoate | - |
Leishmania donovani | 5-aminolevulinate + pyruvate | - |
ir | |
2.6.1.43 | L-alanine + 4,5-dioxopentanoate | first committed step in heme synthesis | Leishmania donovani | 5-aminolevulinate + pyruvate | - |
ir | |
2.6.1.43 | L-glutamate + 4,5-dioxopentanoate | 43.8% of the activity with L-alanine | Leishmania donovani | 5-aminolevulinate + 2-oxoglutarate | - |
ir | |
2.6.1.43 | L-phenylalanine + 4,5-dioxopentanoate | 90.6% of the activity with L-alanine | Leishmania donovani | phenylpyruvate + 5-aminolevulinate | - |
ir | |
2.6.1.43 | additional information | cysteine is no substrate | Leishmania donovani | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.6.1.43 | EC 2.6.1.40 | dimethylarginine-pyruvate aminotransferase and D-3-aminoisobutyrate pyruvate aminotransferase activities resides in the same protein | Leishmania donovani |
2.6.1.43 | EC 2.6.1.44 | alanine-glyoxylate transaminase and aminolevulinate transaminase activities reside in the same protein | Leishmania donovani |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.6.1.43 | 65 | - |
- |
Leishmania donovani |